药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cinolazepam
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Dexamethasone isonicotinate is combined with Hydrocortisone butyrate.
Cinolazepam
Meprednisone
The risk or severity of adverse effects can be increased when Meprednisone is combined with Hydrocortisone butyrate.
Cinolazepam
Fluprednisolone
The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Hydrocortisone butyrate.
Cinolazepam
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Hydrocortisone butyrate.
Cinolazepam
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Hydrocortisone butyrate.
Cinolazepam
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Hydrocortisone butyrate.
Cinolazepam
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone butyrate.
Cinolazepam
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Hydrocortisone butyrate.
Cinolazepam
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Hydrocortisone butyrate.
Cinolazepam
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone butyrate.
Cinolazepam
Fluprednidene
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone butyrate.
Cinolazepam
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Hydrocortisone butyrate.
Cinolazepam
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Hydrocortisone butyrate.
Cinolazepam
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Hydrocortisone butyrate.
Cinolazepam
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Hydrocortisone butyrate.
Cinolazepam
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Hydrocortisone butyrate.
Cinolazepam
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Hydrocortisone butyrate.
Cinolazepam
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Hydrocortisone butyrate.
Cinolazepam
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Hydrocortisone butyrate.
Cinolazepam
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Hydrocortisone butyrate.